Ceptur Therapeutics
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- $28M
Investors
- 8
About Ceptur Therapeutics
Based in New Jersey, US, and founded in 2008, Ceptur Therapeutics, Inc. operates as a biotechnology company that develops genetic medicines for patients with unaddressed diseases based on U1 Adaptor technology. In 2021 the company licensed and expanded the foundational IP portfolio on U1 Adaptor technology and recruited industry leaders in oligonucleotide therapeutics. New members of Ceptur's Scientific Advisory Board include Dr. Thomas L. Andresen, CEO of T-Cypher Bio, Dr. Steven. F. Dowdy, professor of Cellular & Molecular Medicine at UCSD, and other doctors. Ceptur develops genetic medicines using its U1 Adaptor technology. The U1 adaptors are used to engage a ribonucleoprotein splicing factor which is used to promote gene silencing. This therapy can be used to tackle a wide range of diseases in oncology, the central nervous system, nephrology, and immunology.
Who invested in Ceptur Therapeutics
8 investors across 2 rounds
See all investors in Ceptur Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ceptur Therapeutics
Who invested in Ceptur Therapeutics?
Ceptur Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ceptur Therapeutics raised?
Ceptur Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ceptur Therapeutics last raise money?
Ceptur Therapeutics's most recent round on record is a Series A, in Jan 2022.
What does Ceptur Therapeutics do?
Based in New Jersey, US, and founded in 2008, Ceptur Therapeutics, Inc.
Where is Ceptur Therapeutics headquartered?
Ceptur Therapeutics is headquartered in US.
Which VCs invest in companies like Ceptur Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ceptur Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ceptur Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.